The impact of generic competitive strategies on corporate R&D: An empirical study in Japan

被引:7
|
作者
Liao, ZQ [1 ]
Greenfield, PF [1 ]
机构
[1] UNIV QUEENSLAND,OFF PRO VICE CHANCELLOR,BRISBANE,QLD 4072,AUSTRALIA
关键词
generic competitive strategies; R&D; strategic management; technology-based companies; Japan;
D O I
10.1504/IJTM.1997.001687
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This project sought to explore the impact of generic competitive strategies on corporate research and development (R&D) in Japanese technology-based companies through an extensive survey. It results in the generation of information on how Japanese firms approach the integration of R&D and corporate strategic management. Research hypotheses are empirically tested on the basis of the feedback provided by R&D managers from eighty-five leading companies in Japan. The results suggest that both cost leadership and differentiation have considerable impact on corporate R&D. However, Japanese managers particularly place great emphasis on the overall differentiation, because the strategy enables companies to satisfy the increasing demand of customers from a broad range of market segments, We also find out that Japanese managers in different types of industries and different sizes of firms tend to perceive each generic strategic alternative similarly important. Finally, we conclude that consistency with a firm's competitive strategy is considered essential for strategic R&D management.
引用
收藏
页码:542 / 553
页数:12
相关论文
共 50 条
  • [21] Corporate R&D scorecard
    Technology Review, 2000, 103 (06):
  • [22] Pharmaceutical regulation in Europe and its impact on corporate R&D
    Eger, Stephan
    Mahlich, Joerg C.
    HEALTH ECONOMICS REVIEW, 2014, 4
  • [23] PHARMACEUTICAL REGULATION IN EUROPE AND ITS IMPACT ON CORPORATE R&D
    Mahlich, J.
    Eger, S.
    VALUE IN HEALTH, 2013, 16 (07) : A487 - A487
  • [24] Does director interlock impact corporate R&D investment?
    Han, Jie
    Bose, Indranil
    Hu, Nan
    Qi, Baolei
    Tian, Gaoliang
    DECISION SUPPORT SYSTEMS, 2015, 71 : 28 - 36
  • [25] Pharmaceutical regulation in Europe and its impact on corporate R&D
    Stephan Eger
    Jörg C Mahlich
    Health Economics Review, 4 (1)
  • [26] The impact of technology export regulations on corporate R&D investments
    Li, Haoyang
    Wu, Di
    Chen, Jingwei
    Chan, Kam C.
    BORSA ISTANBUL REVIEW, 2023, 23 (02) : 322 - 333
  • [27] Study of CEO Narcissism and Corporate R&D Investment
    Wang, Linan
    Li, Huiying
    Mu, Yinghan
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [28] The decentralization of R&D in Chinese corporation and regional agglomerations of R&D: An empirical study in Beijing
    Wang, Zhiwei
    Chen, Jin
    2006 IEEE INTERNATIONAL CONFERENCE ON MANAGEMENT OF INNOVATION AND TECHNOLOGY, VOLS 1 AND 2, PROCEEDINGS, 2006, : 703 - +
  • [29] An Empirical Analysis of the Impact of R&D on Productivity in EU Countries
    Mykolenko, O.
    Strapchuk, S.
    Kozyreva, O.
    EUROPEAN FINANCIAL SYSTEMS 2019, 2019, : 377 - 384
  • [30] R&D intensity and acquisition and divestiture of corporate assets: Evidence from Japan
    Ushijima, Tatsuo
    JOURNAL OF ECONOMICS AND BUSINESS, 2009, 61 (05) : 415 - 433